WASOFF EVAN L (Chief Financial Officer) received a stock award from NEXIEN BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/17/2023ACC: 0001214659-23-000679
Officer· Chief Financial Officer
Since Jul 2018
+250K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
250K acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+250K
Price / share
—
Trade value
—
% of position
7.1%
1/17/2023
3.50M→3.75M
Total
Net shares
+250K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 1/17/2023 | A · Award | +250K | — | — | 7.1% | 3.50M | 3.75M |
| Total | +250K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)0
No non-derivative holdings reported
Derivative Holdings (Post-Transaction)3
Options to purchase common stock (right to buy)
DirectUnderlying security
common stock
Underlying shares
420K
Shares owned
420K
Exercise price
0.54
Expiration
—
Exercise window
—
Options to purchase common stock (right to buy)
DirectUnderlying security
common stock
Underlying shares
1.50M
Shares owned
1.50M
Exercise price
0.08
Expiration
—
Exercise window
—
Options to purchase common stock (right to buy)
DirectUnderlying security
common stock
Underlying shares
200K
Shares owned
200K
Exercise price
0.655
Expiration
—
Exercise window
—
Total
Underlying
2.12M
Owned
2.12M
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Options to purchase common stock (right to buy) Direct | common stock | 0.54 | — | — | 420K | 420K |
| Options to purchase common stock (right to buy) Direct | common stock | 0.08 | — | — | 1.50M | 1.50M |
| Options to purchase common stock (right to buy) Direct | common stock | 0.655 | — | — | 200K | 200K |
| Total | 2.12M | 2.12M | ||||